COVID-19 outbreak management: Dos and Don'ts
The SARS-Cov-2 outbreak, announced as a pandemic by the world health organization (WHO), is an unprecedented health threat that the world is facing. The virus is spreading fast, putting so many lives at risk. It is time to be open about this outbreak, deal with it efficiently, and contain it as far as possible. Pneumonia caused by SARS-CoV-2 has displayed substantial mortality rates. Without a vaccine to prevent COVID-19 or any medication to treat it, this trend will probably continue. However, the importance of maintaining hand hygiene and social distancing to prevent the spread of disease cannot be emphasized more. A world-wide breathtaking effort is being made to combat the disease. In these days, the necessity of a rapid exchange of information, preliminary findings and hypotheses among scientists, researchers, public health practitioners and health policy makers is undeniable.  One of the most reliable media for this interaction is the sharing of Preprints published in medical, clinical, and related health sciences journals. Preprints are initial reports of research or trials that have not been peer-reviewed. Therefore, Pharmaceutical Sciences intends to allocate a special issue for immediate publication of Preprints in the field of COVID-19 outbreak management, Dos and Don'ts.
Pharmaceutical Sciences will act as an open source platform for rapid review of preprints related to the COVID-19 pandemic. Preprints will be peer-reviewed and accepted at the discretion of the editorial team. The journal will publish academic articles such as letter to editor, commentary, short review, case report, communication, technical note, and hypothesis. 
Before submitting a preprint, please make sure that the manuscript has not been submitted to other preprint servers. When using ideas or findings from others work, proper referencing should be undertaken or if required, permission from the original author must be sought. All authors must avoid plagiarism, knowingly providing false data, image manipulation, data fabrication, and failure to declare conflicts of interest and contributions.
Authors are requested to submit their manuscript online through the following link: https://ps.tbzmed.ac.ir/Login

List of the accepted manuscript:

1. Prophylactic use of chloroquine may impair innate immune system response against SARS-Cov-2
Hamid Soraya
doi: 10.34172/PS.2020.29

 Review Article
2. COVID-19: A devastating pandemic
Punet Kumar, Md Iftekhar Amhad, Sangam Singh
doi: 10.34172/PS.2020.34

Mini-Review Article
3. NSAIDs and COVID-19: a new challenging area
Hananeh Baradaran, Hadi Hamishehkar, Haleh Rezae
doi: 10.34172/PS.2020.34

Indexing & Abstracting:


CiteScore (2018): 1.33
SJR (2018): 0.252
SNIP (2018): 0.656

  SCImago Journal & Country Rank


Follower of ICMJE

Follower of COPE

Powered by:

Dr. Mohammad Reza Siahi

Dr. Alireza Garjani